These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30654725)

  • 1. Effect And Predictive Value Of Routine Preoperative Laboratory Testing For Endoscopic Retrograde Cholangiopancreatography.
    Jokelainen J; Ismail S; Kylänpää L; Udd M; Mustonen H; Lindström O; Pöyhiä R
    Scand J Surg; 2020 Jun; 109(2):115-120. PubMed ID: 30654725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic Retrograde Cholangiopancreatography in Kidney Transplant Patients: Results From a Single Center.
    Öcal S; Harmancı Ö; Ensaroğlu F; Korkmaz M; Selçuk H; Hilmioğlu F; Moray G; Haberal M
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():93-6. PubMed ID: 26640924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How patient-controlled sedation is adopted in clinical practice of sedation for endoscopic retrograde cholangiopancreatography? A prospective study of 1196 cases
    Jokelainen J; Udd M; Kylänpää L; Mustonen H; Halttunen J; Lindström O; Pöyhiä R
    Scand J Gastroenterol; 2017 Feb; 52(2):166-172. PubMed ID: 27705012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial.
    Luo H; Zhao L; Leung J; Zhang R; Liu Z; Wang X; Wang B; Nie Z; Lei T; Li X; Zhou W; Zhang L; Wang Q; Li M; Zhou Y; Liu Q; Sun H; Wang Z; Liang S; Guo X; Tao Q; Wu K; Pan Y; Guo X; Fan D
    Lancet; 2016 Jun; 387(10035):2293-2301. PubMed ID: 27133971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sedation-related complications during anesthesiologist-administered sedation for endoscopic retrograde cholangiopancreatography: a prospective study.
    Zhang CC; Ganion N; Knebel P; Bopp C; Brenner T; Weigand MA; Sauer P; Schaible A
    BMC Anesthesiol; 2020 May; 20(1):131. PubMed ID: 32466744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative versus postoperative endoscopic retrograde cholangiopancreatography in mild to moderate gallstone pancreatitis: a prospective randomized trial.
    Chang L; Lo S; Stabile BE; Lewis RJ; Toosie K; de Virgilio C
    Ann Surg; 2000 Jan; 231(1):82-7. PubMed ID: 10636106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of choledocholithiasis in patients with gallstones and abnormal liver function.
    Al-Jiffry BO; Elfateh A; Chundrigar T; Othman B; Almalki O; Rayza F; Niyaz H; Elmakhzangy H; Hatem M
    World J Gastroenterol; 2013 Sep; 19(35):5877-82. PubMed ID: 24124333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National trends and outcomes in timing of ERCP in patients with cholangitis.
    Seo YJ; Hadaya J; Sareh S; Aguayo E; de Virgilio CM; Benharash P
    Surgery; 2020 Sep; 168(3):426-433. PubMed ID: 32611515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Admission Laboratory Values and the Timing of Endoscopic Retrograde Cholangiopancreatography With Clinical Outcomes in Acute Cholangitis.
    Schwed AC; Boggs MM; Pham XD; Watanabe DM; Bermudez MC; Kaji AH; Kim DY; Plurad DS; Saltzman DJ; de Virgilio C
    JAMA Surg; 2016 Nov; 151(11):1039-1045. PubMed ID: 27557050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: testing the current guidelines.
    Rubin MI; Thosani NC; Tanikella R; Wolf DS; Fallon MB; Lukens FJ
    Dig Liver Dis; 2013 Sep; 45(9):744-9. PubMed ID: 23540659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an Online App to Predict Post-Endoscopic Retrograde Cholangiopancreatography Adverse Events Using a Single-Center Retrospective Cohort.
    Rodrigues-Pinto E; Morais R; Sousa-Pinto B; Ferreira da Silva J; Costa-Moreira P; Santos AL; Silva M; Coelho R; Gaspar R; Peixoto A; Dias E; Baron TH; Vilas-Boas F; Moutinho-Ribeiro P; Pereira P; Macedo G
    Dig Dis; 2021; 39(3):283-293. PubMed ID: 33429393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
    Pekgöz M
    World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failed biliary cannulation: clinical and technical outcomes after tertiary referral endoscopic retrograde cholangiopancreatography.
    Swan MP; Bourke MJ; Williams SJ; Alexander S; Moss A; Hope R; Ruppin D
    World J Gastroenterol; 2011 Dec; 17(45):4993-8. PubMed ID: 22174549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxapram as an additive to propofol sedation for endoscopic retrograde cholangiopancreatography: a placebo-controlled, randomized, double-blinded study.
    Jokelainen J; Belozerskikh A; Mustonen H; Udd M; Kylänpää L; Lindström O; Mazanikov M; Pöyhiä R
    Surg Endosc; 2020 Dec; 34(12):5477-5483. PubMed ID: 31993819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of complications of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound in an ambulatory endoscopy center.
    Mahnke D; Chen YK; Antillon MR; Brown WR; Mattison R; Shah RJ
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):924-30. PubMed ID: 16797251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic retrograde cholangiopancreatography-related adverse events in patients with type 1 autoimmune pancreatitis.
    Naitoh I; Nakazawa T; Okumura F; Takada H; Hirano A; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Yamashita H; Sano H; Ohara H; Joh T
    Pancreatology; 2016; 16(1):78-82. PubMed ID: 26626204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for endoscopic retrograde cholangiopancreatography-related cholangitis: a prospective study.
    Ertuğrul I; Yüksel I; Parlak E; Ciçek B; Ataseven H; Başar O; Ibiş M; Saşmaz N; Sahin B
    Turk J Gastroenterol; 2009 Jun; 20(2):116-21. PubMed ID: 19530044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.